IL37904A0 - Composition and method for treatment of hepatic diseases and mental fatigue - Google Patents

Composition and method for treatment of hepatic diseases and mental fatigue

Info

Publication number
IL37904A0
IL37904A0 IL37904A IL3790471A IL37904A0 IL 37904 A0 IL37904 A0 IL 37904A0 IL 37904 A IL37904 A IL 37904A IL 3790471 A IL3790471 A IL 3790471A IL 37904 A0 IL37904 A0 IL 37904A0
Authority
IL
Israel
Prior art keywords
treatment
composition
mental fatigue
hepatic diseases
hepatic
Prior art date
Application number
IL37904A
Original Assignee
Richardson Merrell Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Spa filed Critical Richardson Merrell Spa
Publication of IL37904A0 publication Critical patent/IL37904A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL37904A 1970-10-15 1971-10-12 Composition and method for treatment of hepatic diseases and mental fatigue IL37904A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8093670A 1970-10-15 1970-10-15

Publications (1)

Publication Number Publication Date
IL37904A0 true IL37904A0 (en) 1971-12-29

Family

ID=22160611

Family Applications (1)

Application Number Title Priority Date Filing Date
IL37904A IL37904A0 (en) 1970-10-15 1971-10-12 Composition and method for treatment of hepatic diseases and mental fatigue

Country Status (9)

Country Link
AU (1) AU3460571A (en)
BE (1) BE773910A (en)
DE (1) DE2150900A1 (en)
FR (1) FR2110465A1 (en)
GB (1) GB1310658A (en)
IL (1) IL37904A0 (en)
NL (1) NL7114199A (en)
PH (1) PH12920A (en)
ZA (1) ZA716628B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059775B1 (en) * 1980-06-09 1984-09-19 Leopold & Co. Chem. pharm. Fabrik Gesellschaft m.b.H. Infusion solution for the protection of the liver and the improvement of its functioning, and process for its production
GB2199243A (en) * 1986-09-17 1988-07-06 Natural Vitality Ltd Pharmaceutical compositions comprising ornithine and arginine
ES2038733T3 (en) * 1987-12-04 1993-08-01 Asta Medica Ag PROCEDURE FOR PREPARING AN INJECTABLE SOLUTION OF THIOCTIC ACID SALT WITH THROMETHANOL AND / OR BASIC AMINO ACIDS.
US5334612A (en) * 1988-11-09 1994-08-02 Asta Pharma Aktiengesellschaft Pharmaceutical compositions containing as active substance sulphur-containing carboxylic acids and their use in combating retroviruses
FR2791571B1 (en) * 1999-04-02 2002-10-04 Sod Conseils Rech Applic ASSOCIATION OF NO SYNTHASE INHIBITOR (S) AND METABOLIC ANTIOXIDANT (S)
US6346382B1 (en) 1999-06-01 2002-02-12 Vanderbilt University Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
US9486429B2 (en) * 1999-06-01 2016-11-08 Vanderbilt University Therapeutic methods employing nitric oxide precursors
EP1255454A2 (en) * 2000-02-01 2002-11-13 Muscletech Research and Development Inc. Alpha lipoic acid based food supplement to increase lean muscle mass and strength
JP3907964B2 (en) * 2001-04-25 2007-04-18 株式会社 伊藤園 Mental fatigue reducing composition, concentration maintenance enhancing composition and mental vitality maintenance enhancing composition
KR20050009718A (en) * 2002-05-29 2005-01-25 유니레버 엔.브이. Odor control in amine salt containing cosmetic composition
EP2319581B1 (en) 2004-11-26 2015-02-25 UCL Business PLC Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
JP5210636B2 (en) * 2005-10-04 2013-06-12 協和発酵バイオ株式会社 Composition for improving subjective symptoms of fatigue
JP5085541B2 (en) * 2006-06-07 2012-11-28 協和発酵バイオ株式会社 Fatigue reducing agent
US8945655B2 (en) 2007-07-10 2015-02-03 Conopco, Inc. Stable and consumable compositions
ES2732810T3 (en) 2008-01-31 2019-11-26 Univ Vanderbilt Procedures and compositions for the treatment of coronary and arterial subarachnoid aneurysmal hemorrhage
WO2010115055A1 (en) 2009-04-03 2010-10-07 Ocera Therapeutics, Inc. L-ornithine phenyl acetate and methods of making thereof
AU2010258888B2 (en) 2009-06-08 2014-08-07 Ocera Therapeutics, Inc. Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate
EA028395B1 (en) 2010-10-06 2017-11-30 Осера Терапьютикс, Инк. Methods of making l-ornithine phenyl acetate
BR112017010761B1 (en) 2014-11-24 2022-10-18 Ucl Business Plc TREATMENT OF DISEASES ASSOCIATED WITH HEPATIC STARTED CELL ACTIVATION WITH THE USE OF AMMONIA REDUCTION THERAPIES
EP3337473A4 (en) 2015-08-18 2019-04-17 Ocera Therapeutics, Inc. Treatment and prevention of muscle loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate
KR20200024145A (en) 2017-05-11 2020-03-06 오세라 테라퓨틱스, 아이엔씨. Method for preparing L-ornithine phenyl acetate

Also Published As

Publication number Publication date
NL7114199A (en) 1972-04-18
ZA716628B (en) 1972-06-28
AU3460571A (en) 1973-04-19
PH12920A (en) 1979-10-10
DE2150900A1 (en) 1972-04-20
BE773910A (en) 1972-01-31
GB1310658A (en) 1973-03-21
FR2110465A1 (en) 1972-06-02

Similar Documents

Publication Publication Date Title
PH12920A (en) Composition and method for treatment of hepatic diseases and mental fatigue
ZA718284B (en) Method and apparatus for the continuous treatment of fibrous materials
IL37098A0 (en) Skin treatment composition and its preparation
GB1368201A (en) Treatment of diseases of the skin and mucosa
PH10336A (en) Nono-chromone-2-carboxylic acid and method and composition for the treatment of asthma
IL36045A0 (en) New pregnane derivative and process of preparation
ZA71320B (en) Process and apparatus for the continuous treatment of threads
ZA728567B (en) Method and compositions for the treatment of human hair
CS190371B2 (en) Means for destroying the phytopatogenous organism and method of making the active agents
ZA713249B (en) Therapeutic process and compositions
ZA713073B (en) Anthelmintic composition and method of use
BE765352A (en) METHOD AND COMPOSITION FOR THE TREATMENT OF
AU458749B2 (en) Process for the treatment and care of dentures
AU464700B2 (en) Composition and method of treatment
AU462834B2 (en) Pharmaceutical composition and method of treatment
BE774917A (en) COMPOSITION FOR THE TREATMENT OF THE HAIR AND METHOD FOR PREPARING THIS COMPOSITION
IL37953A0 (en) Substituted oxazepines and method of use
IL37923A0 (en) Process for the treatment of dentures with silicon oil
CA837050A (en) Method of and composition for the treatment of human carcinoma and hypercholestrolemia
CH537160A (en) Equipment for fermentation and / or heat treatment of tobacco
IE35467B1 (en) Treatment of fats and oils
ZA708706B (en) Antheilmintic composition and method of use
ZA711821B (en) Pharmaceutical compositions and methods of treatment
ZA71461B (en) Method of treating parkinson's disease
ZA714297B (en) Process for the treatment of woollen material and blends thereof